Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab
about
Biopharmaceuticals from microorganisms: from production to purificationTechnological Microbiology: Development and ApplicationsThe Emerging Importance of IgG Fab Glycosylation in Immunity.Sweet but dangerous - the role of immunoglobulin G glycosylation in autoimmunity and inflammation.Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy.De Novo Sequencing and Resurrection of a Human Astrovirus-Neutralizing Antibody.Variable Domain N-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody Stability.
P2860
Q28066997-1BD691FF-73E3-4668-A1ED-6BC0668DF81AQ30250972-96B55C35-04C0-4A8B-8909-A3F95E858C09Q38724772-8DE3CC44-7093-4473-95B0-5FE2CBDECFA7Q38851112-E8A21892-8D75-406A-91E5-027644FE853DQ39062945-AF6F02B0-431E-4B74-84D0-FDB04E836474Q40663787-4C698806-D1D7-4DD5-99F3-B0D7EBA3777BQ55091658-F302C9DF-9F84-4DC0-A92E-82044B3B5B78
P2860
Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Rational design of therapeutic ...... motifs applied to bevacizumab
@en
type
label
Rational design of therapeutic ...... motifs applied to bevacizumab
@en
prefLabel
Rational design of therapeutic ...... motifs applied to bevacizumab
@en
P2093
P2860
P921
P1476
Rational design of therapeutic ...... motifs applied to bevacizumab
@en
P2093
Bernhardt L Trout
Fabienne Courtois
Neeraj J Agrawal
Timothy M Lauer
P2860
P304
P356
10.1080/19420862.2015.1112477
P577
2015-10-29T00:00:00Z